Respiratory motion negatively affects PET/CT image quality and quantitation. A novel Pulsatile-Flow Ventilation (PFV) system reducing respiratory motion was applied in spontaneously breathing patients to induce sustained apnea during PET/CT. Methods: Four patients (aged 65 ± 14 y) underwent PET/CT for pulmonary nodule staging (mean, 11 ± 7 mm; range, 5-18 mm) at 63 ± 3 min after 18 F-FDG injection and then at 47 ± 7 min afterward, during PFV-induced apnea (with imaging lasting $8.5 min). Anterior-posterior thoracic amplitude, SUV max , and SUV peak (SUV mean in a 1-cm-diameter sphere) were compared. Results: PFV PET/CT reduced thoracic amplitude (80%), increased mean lesion SUV max (29%) and SUV peak (11%), decreased lung background SUV peak (25%), improved lesion detectability, and increased SUV peak lesion-to-background ratio (54%). On linear regressions, SUV max and SUV peak significantly improved (by 35% and 23%, respectively; P # 0.02). Conclusion: PFV-induced apnea reduces thoracic organ motion and increases lesion SUV, detectability, and delineation, thus potentially affecting patient management by improving diagnosis, prognostication, monitoring, and external-radiation therapy planning.